Collegium Pharmaceutical launches $50M accelerated share repurchase
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) has entered into an accelerated share repurchase (ASR) agreement with Jefferies LLC to repurchase $50 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
